Throughout time, knowledge has been acquired to understand the world we live in and its interaction with nature. Modern science classified them into different fields to study in various degrees of details. In the last decades the discoveries obtained have brought together to support in our singularity to survive time and diseases. Thus, nature remains to be the inspiration that enables scientists to work in an interdisciplinary environment to discover drugs and develop treatments for old and new infirmities.
Humanity continues to fight against diseases, through interdisciplinary effort and approaches from microbiology, environmental toxicology, immunology, pharmacology, molecular biology and other fields; our capacity to survive diseases and live longer and healthier is greater than ever before. However, one of the challenges concern on a deep understanding of the disease biology, diagnostic and equity of sources to bring solutions for all over the globe.
Our aim is to present new research regarding basic and applied knowledge of old and emerging diseases, from malaria to cancer. Furthermore, to introduce new technology that develop faster and cheaper diagnostic (e.g. CRISPR/Cas9) is in the light of equity for the right treatment of diseases.
The scope of the research includes Pharmacology and interacting fields to achieve the new technologies being developed to understand and treat diseases. From basic research to applied projects.
Research articles may include one of the following topics:
- New technologies for drug discoveries.
- Advances in CRISPR-Cas system for faster and/or cheaper diagnostics of diseases
- Use of animal models to find the best drug treatment of diseases. For example: avatars for cancer
- Use of animal models to understand the drug metabolism and/or toxicity in the organism
- The use of animal models and/or cell culture to investigate acquired/or genetic disease development.
Throughout time, knowledge has been acquired to understand the world we live in and its interaction with nature. Modern science classified them into different fields to study in various degrees of details. In the last decades the discoveries obtained have brought together to support in our singularity to survive time and diseases. Thus, nature remains to be the inspiration that enables scientists to work in an interdisciplinary environment to discover drugs and develop treatments for old and new infirmities.
Humanity continues to fight against diseases, through interdisciplinary effort and approaches from microbiology, environmental toxicology, immunology, pharmacology, molecular biology and other fields; our capacity to survive diseases and live longer and healthier is greater than ever before. However, one of the challenges concern on a deep understanding of the disease biology, diagnostic and equity of sources to bring solutions for all over the globe.
Our aim is to present new research regarding basic and applied knowledge of old and emerging diseases, from malaria to cancer. Furthermore, to introduce new technology that develop faster and cheaper diagnostic (e.g. CRISPR/Cas9) is in the light of equity for the right treatment of diseases.
The scope of the research includes Pharmacology and interacting fields to achieve the new technologies being developed to understand and treat diseases. From basic research to applied projects.
Research articles may include one of the following topics:
- New technologies for drug discoveries.
- Advances in CRISPR-Cas system for faster and/or cheaper diagnostics of diseases
- Use of animal models to find the best drug treatment of diseases. For example: avatars for cancer
- Use of animal models to understand the drug metabolism and/or toxicity in the organism
- The use of animal models and/or cell culture to investigate acquired/or genetic disease development.
